Marty Makary: The FDA’s Quiet Blockade on Safer Nicotine
There are moments in public health when the path forward is unusually clear, when the evidence aligns with behavior, and when policy has a genuine opportunity to reduce harm at scale. This should be one of those moments.
Marty Makary: The FDA’s Quiet Blockade on Safer Nicotine Continue Reading










